Your browser doesn't support javascript.
loading
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study.
Thaçi, Diamant; Puig, Lluís; Reich, Kristian; Tsai, Tsen-Fang; Tyring, Stephen; Kingo, Külli; Ziv, Michael; Pinter, Andreas; Vender, Ronald; Lacombe, Aude; Xia, Summer; Bhosekar, Vaishali; Gilloteau, Isabelle; Guana, Adriana; Blauvelt, Andrew.
Afiliación
  • Thaçi D; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. Electronic address: diamant.thaci@uksh.de.
  • Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Reich K; Dermatologikum Berlin and SCIderm Research Institute, Hamburg, Germany.
  • Tsai TF; Department of Dermatology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Tyring S; University of Texas Health Science Center and Center for Clinical Studies, Houston, Texas.
  • Kingo K; Dermatology Clinic, Tartu University Hospital, Department of Dermatology, University of Tartu, Tartu, Estonia.
  • Ziv M; Emek Medical Center, Afula, Israel.
  • Pinter A; Department of Dermatology, University of Frankfurt, Frankfurt am Main, Germany.
  • Vender R; Dermatrials Research Inc, Hamilton, Canada; Venderm Innovations in Psoriasis, Hamilton, Canada.
  • Lacombe A; Novartis Pharma AG, Basel, Switzerland.
  • Xia S; Novartis Beijing Novartis Pharma Co Ltd, Shanghai, China.
  • Bhosekar V; Novartis Healthcare Pvt Ltd, Hyderabad, India.
  • Gilloteau I; Novartis Pharma AG, Basel, Switzerland.
  • Guana A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Blauvelt A; Oregon Medical Research Center, Portland, Oregon.
J Am Acad Dermatol ; 81(6): 1405-1409, 2019 12.
Article en En | MEDLINE | ID: mdl-31399223
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Anticuerpos Monoclonales Humanizados / Ustekinumab / Medición de Resultados Informados por el Paciente Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: J Am Acad Dermatol Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Fármacos Dermatológicos / Anticuerpos Monoclonales Humanizados / Ustekinumab / Medición de Resultados Informados por el Paciente Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: J Am Acad Dermatol Año: 2019 Tipo del documento: Article